BCL2L10 and lung carcinoma: The absence of BCL2L10 expression in cell lines from leukemia and from breast, prostate, colorectal, and lung cancers in this study is difficult to reconcile with the later observation that BCL2L10 is overexpressed in all these tumor types [27,28,29,30].